Shares Outstanding Shares Outstanding n/a Close	62.71M
Shares Change (YoY) Shares Change (YoY) n/a Close	-0.19%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-0.23%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	19.93%
Shares Floating Shares Floating n/a Close	36.76M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	850
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.62%

Short Selling Information

The latest short interest is 747.45K, so 1.24% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	747.45K
Short % of Shares Out Short % of Shares Out n/a Close	1.24%
Short % of Float Short % of Float n/a Close	2.19%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	4.79

Valuation Ratios

The PE ratio is 215.64 and the forward PE ratio is 23.3. Bioceres Crop Solutions's PEG ratio is -2.6.

PE Ratio PE Ratio n/a Close	215.64
Forward PE Forward PE n/a Close	23.3
PS Ratio PS Ratio n/a Close	1.5
Forward PS Forward PS n/a Close	0.5
PB Ratio PB Ratio n/a Close	2.23
P/FCF Ratio P/FCF Ratio n/a Close	36.94
PEG Ratio PEG Ratio n/a Close	-2.6

Financial Ratio History

Enterprise Valuation

Bioceres Crop Solutions has an Enterprise Value (EV) of 925.88M.

EV / Sales EV / Sales n/a Close	1.99
EV / EBITDA EV / EBITDA n/a Close	16.7
EV / EBIT EV / EBIT n/a Close	22.19
EV / FCF EV / FCF n/a Close	48.9

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.86.

Current Ratio Current Ratio n/a Close	1.24
Quick Ratio Quick Ratio n/a Close	0.86
Debt / Equity Debt / Equity n/a Close	0.86
Debt / EBITDA Debt / EBITDA n/a Close	4.89
Debt / FCF Debt / FCF n/a Close	14.31
Interest Coverage Interest Coverage n/a Close	1.67

Financial Efficiency

Return on Equity is 1.03% and Return on Invested Capital is 4.23%.

Return on Equity Return on Equity n/a Close	1.03%
Return on Assets Return on Assets n/a Close	0.38%
Return on Invested Capital Return on Invested Capital n/a Close	4.23%
Revenue Per Employee Revenue Per Employee n/a Close	$1,162,071.37
Profits Per Employee Profits Per Employee n/a Close	$8,108.4
Employee Count Employee Count n/a Close	400
Asset Turnover Asset Turnover n/a Close	0.55
Inventory Turnover Inventory Turnover n/a Close	2.24

Taxes

Income Tax Income Tax n/a Close	3.78M
Effective Tax Rate Effective Tax Rate n/a Close	37.65%

Stock Price Statistics

The stock price has increased by -58.26% in the last 52 weeks. The beta is 0.44, so Bioceres Crop Solutions's price volatility has been higher than the market average.

Beta Beta n/a Close	0.44
52-Week Price Change 52-Week Price Change n/a Close	-58.26%
50-Day Moving Average 50-Day Moving Average n/a Close	4.56
200-Day Moving Average 200-Day Moving Average n/a Close	5.89
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	47.83
Average Volume (20 Days) Average Volume (20 Days) n/a Close	137,046

Income Statement

In the last 12 months, Bioceres Crop Solutions had revenue of 464.83M and earned 3.24M in profits. Earnings per share was 0.05.

Revenue Revenue n/a Close	464.83M
Gross Profit Gross Profit n/a Close	181.59M
Operating Income Operating Income n/a Close	44.82M
Net Income Net Income n/a Close	3.24M
EBITDA EBITDA n/a Close	55.46M
EBIT EBIT n/a Close	34.16M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	0.05

Full Income Statement

Balance Sheet

The company has 44.47M in cash and 270.95M in debt, giving a net cash position of -226.47M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	44.47M
Total Debt Total Debt n/a Close	270.95M
Net Cash Net Cash n/a Close	-226.47M
Retained Earnings Retained Earnings n/a Close	-10.66M
Total Assets Total Assets n/a Close	835.2M
Working Capital Working Capital n/a Close	94.9M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 41.72M and capital expenditures -22.78M, giving a free cash flow of 18.93M.

Operating Cash Flow Operating Cash Flow n/a Close	41.72M
Capital Expenditures Capital Expenditures n/a Close	-22.78M
Free Cash Flow Free Cash Flow n/a Close	18.93M
FCF Per Share FCF Per Share n/a Close	0.3

Full Cash Flow Statement

Margins

Gross margin is 39.07%, with operating and profit margins of 9.64% and 0.7%.

Gross Margin Gross Margin n/a Close	39.07%
Operating Margin Operating Margin n/a Close	9.64%
Pretax Margin Pretax Margin n/a Close	2.16%
Profit Margin Profit Margin n/a Close	0.7%
EBITDA Margin EBITDA Margin n/a Close	11.93%
EBIT Margin EBIT Margin n/a Close	9.64%
FCF Margin FCF Margin n/a Close	4.07%

Dividends & Yields

BIOX does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	0.46%
FCF Yield FCF Yield n/a Close	2.71%

Dividend Details

Analyst Forecast

The average price target for BIOX is $7, which is 53.2% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$7
Price Target Difference Price Target Difference n/a Close	53.2%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$0.26
Lynch Upside Lynch Upside n/a Close	-94.31%
Graham Number Graham Number n/a Close	2.41
Graham Upside Graham Upside n/a Close	-47.26%

Scores

Altman Z-Score Altman Z-Score n/a Close	1.11
Piotroski F-Score Piotroski F-Score n/a Close	5